Papers
70
Total Citations
2,479
H-Index
31
About
Michele Gallucci stands at the forefront of robotic urologic oncology, with pioneering contributions that have fundamentally reshaped how surgeons approach some of the most technically demanding procedures in the field. Based at a leading Italian center, Gallucci has built an internationally recognized body of work centered on robot-assisted surgery for kidney cancer, bladder cancer, and complex reconstructive urology. His most celebrated contributions include the first reported series of completely intracorporeal robotic Level III inferior vena cava tumor thrombectomy — a procedure previously considered the exclusive domain of open surgery — garnering over 140 citations and establishing a new benchmark for minimally invasive oncologic surgery. His multicenter ROSULA Collaborative Group work on robot-assisted partial nephrectomy for large clinical T2 renal tumors (147 citations) further cemented his reputation as a leader in nephron-sparing innovation. Gallucci has also advanced fluorescence-guided surgery through consensus-building on indocyanine green imaging and introduced a novel trifecta framework for evaluating partial nephrectomy outcomes. His involvement in randomized controlled trials comparing open and robotic radical cystectomy reflects his commitment to evidence-based practice. Collectively, his work — exceeding 900 citations across his top papers — has profoundly influenced global standards in robotic urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic Level III Inferior Vena Cava Tumor Thrombectomy: Initial Series142 citations · 2015
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10